FDA approves new controversial treatment for Alzheimer's patients
The Food and Drug Administration's approval of Biogen's IV treatment for Alzheimer's, Aducanumab, is bringing hope to some advocates for families and caregivers of those with the d…
The Food and Drug Administration's approval of Biogen's IV treatment for Alzheimer's, Aducanumab, is bringing hope to some advocates for families and caregivers of those with the d…